This review identified an overall sero-prevalence of Toxoplasma infection of 40% among pregnant women and HIV/AIDS. The expansion of prevention and control strategies, with a primary focus on enhancing educational initiatives, is necessary to avoid reactivation and stop the spread of infection, so investigative sero-prevalence is important work among pregnant women and HIV patients. In order to achieve a comprehensive explanation of the disease condition and reach this goal, we conducted a systematic review and meta-analysis in Worldwide for future use.
Keyphrases
- hiv aids
- antiretroviral therapy
- pregnant women
- human immunodeficiency virus
- end stage renal disease
- hiv infected
- risk factors
- chronic kidney disease
- hiv positive
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- hepatitis c virus
- hiv testing
- men who have sex with men
- south africa
- toxoplasma gondii
- pregnancy outcomes